Proposition 65 notices, documents and downloads. Search using keyword(s) or use the advanced search to include more search options.
Proposition 65 Notices
Start of 60 day comment period for the request for information on the reproductive and developmental toxicity of mercury and mercury compounds (excluding methyl mercury).
Request for information on the following chemicals under consideration for listing as known to the State to cause cancer or reproductive toxicity: Trimetrexate Glucuronate, Paclitaxel,
Quazepam, Nitrobenzene, Leuprolide Acetate, Ganciclovir Sodium, Goserelin Acetate, Estropipate, Ethionamide, Atenolol, Amiodarone Hydrochloride, C.I. Direct Blue 15, 3,7-Dinitrofluoranthene, 3,9-Dinitrofluoranthene, 1-Amino-2,4-dibromoanthraquinone, C.I. Direct Blue 218, Premarin
OEHHA is soliciting information which may be relevant to the evaluation of the following chemicals under consideration for listing as known to the State to cause cancer or reproductive toxicity: Tr
In a notice dated September 27, 1996, OEHHA announced that these chemicals were under consideration for listing based on a review of information indicating that the chemicals may meet the criteria
Notice of intent to list nine chemicals via the authoritative bodies mechanism or the formally required mechanism as known to the state to cause cancer or reproductive toxicity: Nitromethane, Tetrafluoroethylene, Vinyl fluoride, Spironolactone, Stanozolol, Clarithromycin, Dihydroergotamine mesylate, Hydroxyurea, Oxymetholone
Notice of postponement of prioritization of carbamazepine and progesterone for possible consideration by the Developmental and Reproductive Toxicant Identification Committee.
Comment Period - Request for Information on Chemicals to be Considered by the Carcinogen Identification Committee
Notice of meeting of the Developmental and Reproductive Toxicant (DART) Identification Committee and draft agenda. Chemicals to be reviewed include inorganic arsenic and cadmium.
Announcement of Wednesday, December 4, 1996 meeting of the Developmental and Reproductive Toxicant Identification Committee to consider inorganic arsenic, cadmium, mechanisms for removing chemicals from the Proposition 65 list, and prioritization.
Request for information on chemicals under consideration for possible listing as known to the State to cause cancer: 5-chloro-ortho-toluidine and its hydrochloride (CASRN: 95-79-4); quinoline (CASRN: 91-22-5); 2,4,5-trimethylaniline and its hydrochloride (CASRN: 137-17-7).
Meeting of the Developmental and Reproductive Toxicant Identification Committee to consider listing inorganic arsenic and cadmium.
This final statement of reasons sets forth the reasons for the repeal of Section 12713 (Exposure to Foods, Drugs, Cosmetics, and Medical Devices) and the amendment to Section 12701 (General), and responds to the objections and recommendations submitted regarding these actions.
The purpose of this regulation is to provide "safe harbor" no significant risk levels for an additional 140 chemicals, below which the Act does not apply.
This regulation adopts "no significant risk" levels for Hexachlorodibenzodioxin (HCDD) of 0.0002 microgram per day and 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) of 0.000005 microgram per day.
This regulation adopts "no significant risk" levels in Section 12705, subsection (b), for the following chemicals: Arsenic, Butylated hydroxyanisole, Cadmium, and Chromium (hexavalent compounds).
The purpose of this regulation is to provide "safe harbor" no significant risk levels for dichloromethane (methylene chloride), trichloroethylene, and vinyl chloride.
This regulation adopts no significant risk levels for Benzyl chloride of 4 micrograms per day and Bromodichloromethane of 5 micrograms per day.
The purpose of this regulation is to provide a "safe harbor" level for toluene of 7,000 mlcrograms per day.
This regulation adopts a no significant risk level for benzene of 7 micrograms per day.
This regulation adopts no significant risk levels for: Acrylamide, Allyl Chloride, Aniline, Azobenzene, DDVP (Dichlorvos), Folpet, Furmecyclox, Hydrazine, Hydrazine sulfate, 4,4'-Methylene bis(N,N-dimethyl) benzeneamine, N-Nitrosodiethanolamine, N-Nitrosomethylethylamine, Pentachlorophenol, and Hexachlorocyclohexane (alpha, beta, and gamma isomers).